PRESS RELEASE published on 06/21/2024 at 11:16, 2 years 3 months ago Heidelberg Pharma reports on the results of the Annual General Meeting 2024 Heidelberg Pharma AG reports on the results of the Annual General Meeting 2024, including approval of resolutions and shareholder attendance Shareholders Voting Results Annual General Meeting 2024 Cancer Therapy Heidelberg Pharma AG
BRIEF published on 06/18/2024 at 13:52, 2 years 3 months ago Heidelberg Pharma AG Announces Updated Guidance for 2024 Revenue Forecast Financial Guidance Biotech Heidelberg Pharma AG Operating Expenses
BRIEF published on 06/18/2024 at 13:52, 2 years 3 months ago Heidelberg Pharma AG annonce des prévisions mises à jour pour 2024 Conseils Financiers Prévisions De Revenus Heidelberg Pharma SA Biotechnologies Dépenses De Fonctionnement
PRESS RELEASE published on 06/18/2024 at 13:47, 2 years 3 months ago EQS-Adhoc: Heidelberg Pharma AG announces updated guidance Heidelberg Pharma AG updates guidance for fiscal year 2024, lowering sales expectations due to delays and adjusting operating expenses. Financing secured until mid-2025 with potential expansion until end of 2026 Financial Year 2024 Heidelberg Pharma AG Operating Expenses Sales Expectations Updated Guidance
BRIEF published on 05/23/2024 at 09:17, 2 years 4 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Cancer Treatment Conférences Heidelberg Pharma HDP-101 ADCs
BRIEF published on 05/23/2024 at 09:17, 2 years 4 months ago Heidelberg Pharma participera et présentera des conférences scientifiques de premier plan à venir en mai et juin 2024 Conférences Traitement Du Cancer Heidelberg Pharma HDP-101 ADC
PRESS RELEASE published on 05/23/2024 at 09:12, 2 years 4 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Heidelberg Pharma AG to participate and present at leading scientific conferences in May and June 2024, showcasing innovative ADC technology platforms for cancer treatment Cancer Treatment ADC Technology Heidelberg Pharma AG Scientific Conferences Clinical Stage Biotech
BRIEF published on 04/25/2024 at 07:26, 2 years 5 months ago Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
BRIEF published on 04/25/2024 at 07:26, 2 years 5 months ago Heidelberg Pharma AG publie ses résultats financiers et ses progrès opérationnels pour le premier trimestre 2024 Performance Financière Nomination Du PDG Heidelberg Pharma SA Essai Clinique HDP-101 Développement Du Pipeline ADC
PRESS RELEASE published on 04/25/2024 at 07:21, 2 years 5 months ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma AG reports on its interim management statement for the first three months of 2024, including first efficacy data from a clinical trial and successful financing activities Clinical Trial Heidelberg Pharma AG ADC Pipeline Interim Statement Financing Activities
Published on 10/12/2026 at 22:01, 54 minutes ago Fermi Announces Third Quarter 2026 Earnings Release and Call Date
Published on 10/12/2026 at 15:00, 7 hours 55 minutes ago Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 9 hours 55 minutes ago U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 18 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 20 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/12/2026 at 20:30, 2 hours 25 minutes ago Correction of a release from 29.09.2026 18:15 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:30, 2 hours 25 minutes ago Correction of a release from 02.10.2026 14:59 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:05, 2 hours 49 minutes ago SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Published on 10/12/2026 at 19:10, 3 hours 44 minutes ago Cell Impact announces acceleration of previously communicated order from US customer
Published on 10/12/2026 at 19:00, 3 hours 55 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 5 octobre 2026 au 9 octobre 2026
Published on 10/12/2026 at 17:59, 4 hours 55 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:59, 4 hours 55 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 7 au 9 octobre 2026
Published on 10/12/2026 at 17:45, 5 hours 10 minutes ago Déclaration des transactions sur actions propres réalisées du 05/10/2026 au 11/10/2026
Published on 10/12/2026 at 17:45, 5 hours 10 minutes ago Déclaration hebdomadaire de rachat d'actions
